Effect of Treating Sleep Disorder Breathing in Patients With Resistant Hypertension
Withdrawn before enrolling · Not applicable
Conditions studied: Sleep Apnea, Hypertension
In brief
The investigators would like to investigate the effects of treating sleep apnea with a positive airway pressure device, either continuous (titrated) versus auto titrated on the control of blood pressure in patients with Resistant Hypertension.
Key facts
- Study ID
- NCT00973531
- Run by
- Albert Einstein Healthcare Network
- People needed
- 0
- Starts
- 2009-05-01
- Expected to finish
- 2011-10-01
- Last updated by the study team
- 2012-01-26
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects who are competent to provide written consent
- Aged 18 to 80 years
- Deemed to be compliant with anti-hypertension medication therapy.
- Subjects with diabetes and/or chronic kidney disease must have a mean 24 hour systolic blood pressure ≥130 mmHg
- All other subjects must have a mean 24 hour systolic blood pressure ≥140 mmHg
- Receiving and adhering to full doses of appropriate guideline-recommended antihypertensive drugs from three different classes of antihypertensive agents, preferably including a diuretic
You may not qualify if…
- Average sitting systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg
- Known Sleep apnea
- Subjects who perform alternating shift or night work
- Subjects who have participated in a clinical study involving another investigational drug or device within 4 weeks prior to Screening
- Have hypertension secondary to an identifiable and treatable cause other than sleep apnea
- Subjects taking over the counter medications that can raise blood pressure, such as
- Non narcotic analgesics
- Non steroidal anti-inflammatory agents, including aspirin, Selective COX-2 inhibitors
- Sympathomimetic agents (decongestants, diet pills, cocaine)
- Stimulants (methylphenidate, dexmethylphenidate, dextroamphetamine, amphetamine, methamphetamine, modafinil)
- Alcohol
- Oral contraceptives
- Cyclosporine
- Erythropoietin
- Natural licorice
- Herbal compounds (ephedra or ma huang)
Where it is running
- Albert Einstein Medical Center — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.